Literature DB >> 14534691

Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.

Masaya Mukai1, Shinkichi Sato, Tomomi Nishida, Nobukazu Komatsu, Kazuaki Shiba, Hisao Nakasaki, Hiroyasu Makuuchi.   

Abstract

Among 371 patients with primary colorectal cancer, 54 patients suffered from recurrence/metastasis (recurrence group) and 317 survived without recurrence for at least 5 years (non-recurrence group). The clinicopathological characteristics of the 2 groups were compared and occult neoplastic cells (ONCs) in the lymph node sinuses were detected by cytokeratin immunohistochemistry. There were significant differences of the following factors: venous invasion (v-) vs. (v+) for Dukes' A patients (p=0.0315); harvested lymph nodes (LN) <or=14 vs. >or=15 for Dukes' B patients (p=0.0388); (v-) vs. (v+) (p=0.0059), lymphatic invasion (ly-) vs. (ly+) (p=0.0435) for Dukes' A and B patients combined; D>n vs. D=n (p=0.0033), depth of tumor invasion <or=ss/a1 vs. >or=se/a2 (p=0.0329) for Dukes' C patients. When the detection of >or=3 ONCs was defined as positive, the sensitivity, specificity, PPV, and NPV were respectively 77%, 100%, 100% and 71% in Dukes' B patients, as well as 75%, 72%, 73% and 74% in Dukes' C patients. The high-risk groups for recurrence/metastasis were identified by the following criteria: (v+) and (ly+), <or=14 LN, and ONCs (+) of those with all factors for Dukes' A and B patients (selection rate, approximately 23.5%), while the criteria were D=n, >or=se/a2, and ONCs (+) of those with >or=2 factors for Dukes' C patients (selection rate; approximately 21.2-37.5%). These factors seem to be appropriate for separating patients into high-risk and low-risk groups of colorectal cancer recurrence/metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534691

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Significance of occult neoplastic cells on tumor metastasis: a case report of gastric cancer.

Authors:  Shinkichi Sato; Masaya Mukai
Journal:  Diagn Pathol       Date:  2010-02-24       Impact factor: 2.644

Review 2.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 3.  Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Authors:  Lei He; Juan Xiao; Ping Zheng; Lei Zhong; Qian Peng
Journal:  World J Gastrointest Oncol       Date:  2022-08-15

4.  The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer.

Authors:  Hsiang-Lin Tsai; Chien-Yu Lu; Jan-Sing Hsieh; Deng-Chyang Wu; Chang-Ming Jan; Chee-Yin Chai; Koung Shing Chu; Hon-Man Chan; Jaw-Yuan Wang
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

5.  The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.

Authors:  Stefano Scabini; Fabrizio Montecucco; Alessio Nencioni; Gabriele Zoppoli; Marina Sartini; Edoardo Rimini; Andrea Massobrio; Luisito De Marini; Alessandro Poggi; Roberto Boaretto; Emanuele Romairone; Alberto Ballestrero; Valter Ferrando
Journal:  World J Surg Oncol       Date:  2013-11-18       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.